Found 938 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
This study investigates solid tumors. Participants will provide clinical data and biological samples to support cancer biomarker research.The focus of this study is to evaluate the development of tests for cancer detection and assessing the risk of cancer recurrence.Who can participate: Adults aged 18 and older with a confirmed diagnosis …
This is a phase III, double-blind, placebo-controlled study to evaluate the efficacy and safety or NI0752 in participants with Progressive Supranuclear Palsy (PSP). Participants will receive either 50mg of NI0752 or placebo every 12 weeks for 72 weeks via intrathecal injection during the double-blind period followed by an OLE period.
This is a study evaluating SAR446268 as a treatment for DM1. SAR446268 is designed to deliver miRNA to pathological DMPK gene expression that leads to DM1. Patients will receive a 1-time dose of the study drug and then undergo a 5 year follow-up period to monitor safety and efficacy.
This trial will evaluate a noninvasive deep brain stimulation intervention for fibromyalgia. Low-intensity transcranial focused ultrasound (FUS) is delivered to the cingulate cortex using a novel device, DIADEM. The DIADEM system is capable of delivering a known dose of ultrasound with high spatial and temporal precision, thereby modulating the activity …
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients approved by the Patient Screening Committee (PSC) will be randomized to undergo HRPCI with either the Supira System (investigational device) or the …
This is an interventional, multi-centre, randomised, parallel group, double-blind, placebo-controlled, comparator-controlled phase 2 study designed to investigate the safety, tolerability and efficacy of different dose-escalation regimens of s.c. NNC0662-0419 in participants living with obesity.
This study aims to test an adapted version of the Supporting Transitions to Adulthood to Reduce Suicide (STARS) program to increase the use of the Safety Planning Intervention (SPI; an evidence-based treatment for suicidal ideation) and reduce suicidal ideation among young adults (ages 18-34 years). Aim 1 of the study …
The purpose of this study is to evaluate the efficacy and safety of concomitant use of eplontersen and ALXN2220 compared with eplontersen and placebo in adult participants with ATTR-CM who are treated with standard-of-care therapy as determined by the treating and study physician(s). The study duration will be up to …
This research study is being done to learn about the effects of the study drug, Atacicept, on reducing damage to the kidneys and to see how safe the study drug is for people with IgA nephropathy (IgAN), IgA vasculitis with nephritis (IgAVN), primary membranous nephropathy (pMN), minimal change disease (MCD), …
This is a randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a single dose of RE104 (30 mg) versus placebo for the treatment of GAD.
Please choose between Voice or SMS based delivery of verification code
or